BGN and neoplasm: TECs‐biglycan activates nuclear factor‐κB (NF‐kB) and extracellular signal‐regulated kinase (ERK) signal transduction to stimulate the metastasis of tumor cells expressing toll‐like receptors (TLR) and promote tumor angiogenesis of tumors by activating the TLR signaling pathway.150